Notice on Convening the 3rd Extraordinary General Meeting in 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Notice on Convening the 3rd Extraordinary General Meeting in 2026
Filed with SSE · · 10 pages · Chinese
On 6ix: 6ix.com/news/bide-pharmatech-co-ltdnotice-on-convening-the-3rd-extraordinary-general-meeting-in-2026
Release
Bide Pharmatech Co. Ltd. on 6ix
Earlier from Bide Pharmatech
- Announcement on Expiration of Shareholding Reduction Plan by Shareholder and Results of Shareholding Reduction
- Announcement on the Vesting Results for the First Vesting Period of the Initial Grant and Reserved Grant under the 2024 Restricted Share Incentive Plan
- Announcement on Provision for Asset Impairment for the First Half of 2026
- Announcement on Shareholding Reduction Plan of Shareholder
- Indicative Announcement on Shareholder's Equity Change Reaching an Integer Multiple of 5%
Later from Bide Pharmatech
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Resignation of the Securities Affairs Representative
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Convening the 2026 Semi-annual Performance Briefing
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Completion of Election of New Board of Directors and Appointment of Senior Executives
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Election of Employee Representative Director for the 3rd Board of Directors
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
Follow Bide Pharmatech into a list and get an email when it puts out news.
Follow Bide Pharmatech